Gut dysbiosis: Ecological causes and causative effects on human disease

被引:31
|
作者
Winter, Sebastian E. [1 ,2 ]
Baeumler, Andreas J. [2 ]
机构
[1] Univ Calif Davis, Dept Med, Div Infect Dis, Davis, CA 95616 USA
[2] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA
关键词
microbiota; dysbiosis; colitis; colorectal cancer; CHAIN FATTY-ACIDS; ENTERICA SEROVAR TYPHIMURIUM; ACTIVATED-RECEPTOR-GAMMA; INTESTINAL MICROBIOTA; NITRIC-OXIDE; ESCHERICHIA-COLI; SALMONELLA INFECTION; ENHANCED SUSCEPTIBILITY; NITRATE RESPIRATION; ENERGY-METABOLISM;
D O I
10.1073/pnas.2316579120
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The gut microbiota plays a role in many human diseases, but high- throughput sequence analysis does not provide a straightforward path for defining healthy microbial communities. Therefore, understanding mechanisms that drive compositional changes during disease (gut dysbiosis) continues to be a central goal in microbiome research. Insights from the microbial pathogenesis field show that an ecological cause for gut dysbiosis is an increased availability of host- derived respiratory electron acceptors, which are dominant drivers of microbial community composition. Similar changes in the host environment also drive gut dysbiosis in several chronic human illnesses, and a better understanding of the underlying mechanisms informs approaches to causatively link compositional changes in the gut microbiota to an exacerbation of symptoms. The emerging picture suggests that homeostasis is maintained by host functions that control the availability of resources governing microbial growth. Defining dysbiosis as a weakening of these host functions directs attention to the underlying cause and identifies potential targets for therapeutic intervention.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Therapy Used to Promote Disease Remission Targeting Gut Dysbiosis, in UC Patients with Active Disease
    Mirsepasi-Lauridsen, Hengameh Chloe
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [42] Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
    Sagard, Jonas
    Olofsson, Tor
    Mogard, Elisabeth
    Marsal, Jan
    Andreasson, Kristofer
    Geijer, Mats
    Kristensen, Lars Erik
    Lindqvist, Elisabet
    Wallman, Johan K.
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [43] Metabolome of human gut microbiome is predictive of host dysbiosis
    Larsen, Peter E.
    Dai, Yang
    GIGASCIENCE, 2015, 4 : 1 - 16
  • [44] Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis
    Ray, Avijit
    Dittel, Bonnie N.
    IMMUNOLOGY, 2015, 146 (03) : 359 - 368
  • [45] Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
    Jonas Sagard
    Tor Olofsson
    Elisabeth Mogard
    Jan Marsal
    Kristofer Andréasson
    Mats Geijer
    Lars Erik Kristensen
    Elisabet Lindqvist
    Johan K. Wallman
    Arthritis Research & Therapy, 24
  • [46] Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis
    Roshan Kumar
    Utkarsh Sood
    Vipin Gupta
    Mona Singh
    Joy Scaria
    Rup Lal
    Indian Journal of Microbiology, 2020, 60 : 12 - 25
  • [47] Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
    Alshehri, Dikhnah
    Saadah, Omar
    Mosli, Mahmoud
    Edris, Sherif
    Alhindi, Rashad
    Bahieldin, Ahmed
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (03) : 270 - 283
  • [48] The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes
    Sencio, Valentin
    Machado, Marina Gomes
    Trottein, Francois
    MUCOSAL IMMUNOLOGY, 2021, 14 (02) : 296 - 304
  • [49] Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease
    Li, Qinghong
    Larouche-Lebel, Eva
    Loughran, Kerry A.
    Huh, Terry P.
    Suchodolski, Jan S.
    Oyama, Mark A.
    MSYSTEMS, 2021, 6 (02)
  • [50] Effects of senotherapeutics on gut microbiome dysbiosis and intestinal inflammation in Crohn's disease: A pilot study
    Sangfuang, Nannapat
    Mccoubrey, Laura E.
    Awad, Atheer
    Marzorati, Massimo
    Ghyselinck, Jonas
    Verstrepen, Lynn
    De Munck, Julie
    De Medts, Jelle
    Gaisford, Simon
    Basit, Abdul W.
    TRANSLATIONAL RESEARCH, 2025, 278 : 36 - 47